|
Reference |
Supplier |
Description |
Unit |
Price excl. taxes |
|
|
|
EPY0001302 |
European Pharmacopoeia |
Rizatriptan benzoate 200mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001303 |
European Pharmacopoeia |
Rizatriptan for system suitability 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001304 |
European Pharmacopoeia |
Butyl methanesulfonate CRS 30µl |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001305 |
European Pharmacopoeia |
Cefpodoxime proxetil 70mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001306 |
European Pharmacopoeia |
Cefpodoxime proxetil for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001307 |
European Pharmacopoeia |
Costunolide 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001308 |
European Pharmacopoeia |
Glycopyrronium bromide 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001309 |
European Pharmacopoeia |
Glycopyrronium for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001310 |
European Pharmacopoeia |
Meclozine impurity B 4-chlorobenzhydrol 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001311 |
European Pharmacopoeia |
Meclozine impurity H 1-(4-chlorobenzhydryl)piperazine 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001312 |
European Pharmacopoeia |
Testosterone enantate for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001313 |
European Pharmacopoeia |
Testosterone enantate impurity H 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001314 |
European Pharmacopoeia |
1-nonadecanol 425mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001315 |
European Pharmacopoeia |
Josamycin for peak identification 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001316 |
European Pharmacopoeia |
Tropicamide for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001317 |
European Pharmacopoeia |
Testosterone enantate for system suitability *** 2mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001318 |
European Pharmacopoeia |
Cefpodoxime proxetil for impurity H identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001319 |
European Pharmacopoeia |
Trimebutine maleate 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001320 |
European Pharmacopoeia |
Ondansetron impurity F 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001321 |
European Pharmacopoeia |
Dermatan sulfate and oversulfated chondroitin sulfate 1ml |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001322 |
European Pharmacopoeia |
Hydroxyethyl starch (high Mw) 800mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001323 |
European Pharmacopoeia |
Aristolochia TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001324 |
European Pharmacopoeia |
Sucralfate 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001325 |
European Pharmacopoeia |
Equisetum palustre 200mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001326 |
European Pharmacopoeia |
Ondansetron impurity E 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001327 |
European Pharmacopoeia |
Atorvastatine calcium trihydrate 150mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001328 |
European Pharmacopoeia |
Atorvastatin impurity A 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001329 |
European Pharmacopoeia |
Atorvastatin impurity B 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001330 |
European Pharmacopoeia |
Atorvastatin impurity C 5mg |
|
Price on demand
|
|
|
|
EPY0001332 |
European Pharmacopoeia |
Atorvastatin impurity E 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001333 |
European Pharmacopoeia |
Clopidogrel hydrogen sulfate 60mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001334 |
European Pharmacopoeia |
Clopidogrel for system suitability 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001335 |
European Pharmacopoeia |
Clopidogrel impurity A 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001336 |
European Pharmacopoeia |
Cefepime impurity E TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001337 |
European Pharmacopoeia |
Oseltamivir phosphate 300mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001338 |
European Pharmacopoeia |
Oseltamivir impurity A 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001339 |
European Pharmacopoeia |
Oseltamivir impurity B 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001340 |
European Pharmacopoeia |
Oseltamivir impurity C 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001341 |
European Pharmacopoeia |
Oseltamivir impurity H 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001342 |
European Pharmacopoeia |
Sucralose impurity B 0.5mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001344 |
European Pharmacopoeia |
Sucralose 550mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001345 |
European Pharmacopoeia |
Ondansetron impurity A (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001346 |
European Pharmacopoeia |
Ondansetron impurity G (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one(C-demethylondansetron) 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001347 |
European Pharmacopoeia |
Ginsenoside Rb1 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001348 |
European Pharmacopoeia |
Gagapentin impurity B (1-cyanocyclohexyl)acetic acid 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001349 |
European Pharmacopoeia |
Gabapentin impurity D [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001350 |
European Pharmacopoeia |
Phenobarbital impurity A (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001351 |
European Pharmacopoeia |
Phenobarbital impurity B (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001352 |
European Pharmacopoeia |
Nicergoline for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001353 |
European Pharmacopoeia |
Carbon monoxide - reference spectrum TBC |
|
152.32 CHF
165.57 €
|
|
